Volume 13, Number 6—June 2007
Ilheus Virus Isolate from a Human, Ecuador
Highlight and copy the desired format.
|EID||Johnson BW, Cruz C, Felices V, Espinoza WR, Manock SR, Guevara C, et al. Ilheus Virus Isolate from a Human, Ecuador. Emerg Infect Dis. 2007;13(6):956-958. https://dx.doi.org/10.3201/eid1306.070118|
|AMA||Johnson BW, Cruz C, Felices V, et al. Ilheus Virus Isolate from a Human, Ecuador. Emerging Infectious Diseases. 2007;13(6):956-958. doi:10.3201/eid1306.070118.|
|APA||Johnson, B. W., Cruz, C., Felices, V., Espinoza, W. R., Manock, S. R., Guevara, C....Kochel, T. J. (2007). Ilheus Virus Isolate from a Human, Ecuador. Emerging Infectious Diseases, 13(6), 956-958. https://dx.doi.org/10.3201/eid1306.070118.|
To the Editor: Ilheus virus (ILHV) (genus Flavivirus in the Ntaya antigenic complex) is most closely related to Rocio virus. However, antibodies produced during ILHV infection cross-react in serologic assays to other flavivirus antigens, and ILHV was originally classified in the Japanese encephalitis antigenic complex (1–3). ILHV is transmitted in an enzootic cycle between birds and mosquitoes. Since the first isolation of ILHV from a pool of Aedes spp. and Psorophora spp. mosquitoes collected in 1944 at Ilheus City, on the eastern coast of Brazil (4), isolates have been obtained in Central and South America and Trinidad, primarily from Psorophora ferox mosquitoes (5,6). ILHV is not associated with epidemic disease and has been only sporadically isolated from humans (5,7–9). The clinical spectrum of human infections documented by virus isolation ranges from asymptomatic to signs of central nervous system involvement suggestive of encephalitis. Most commonly, patients exhibit a mild febrile illness accompanied by headache, myalgia, arthralgia, and photophobia, symptoms that may result in clinical diagnosis of dengue, Saint Louis encephalitis, yellow fever, or influenza (7). Laboratory diagnosis of ILHV infection may be difficult, unless a virus isolate can be obtained, because of the cross-reactivity in serologic assays to other flaviviruses that circulate in the same area, such as Rocio, dengue, yellow fever, and Saint Louis encephalitis viruses.
On March 1, 2004, after 4 days of symptoms, a 20-year-old male soldier stationed in Lorocachi, Ecuador, was admitted to the Hospital de la IV División del Ejercito “Amazonas” in Puyo, Ecuador. Lorocachi is in the Amazonian province of Pastaza, of which Puyo is the capital. The patient had fever, rash, epistaxis, headache, myalgia, retroocular pain, nausea, vomiting, jaundice, sore throat, and abdominal pain.
A blood specimen (containing isolate FSE800) was collected, and an acute-phase serum sample was processed for virus isolation in C6/36 (Aedes albopictus) and Vero cells. After 3 days, cytopathic effects were observed, and cells were screened by an immunofluorescence assay for reactivity against alphaviruses and flaviviruses by using polyclonal antibodies. The cells gave positive results with yellow fever, Saint Louis encephalitis, Rocio, and Ilheus antisera. Viral RNA was then extracted from the patient’s acute-phase serum and cell supernatants and processed for virus sequencing. Amplification of an ≈250-bp product by SyBRgreen real-time reverse transcriptase PCR and subsequent sequencing of the amplicon were conducted with the flavivirus consensus primers FU1 and cFD2 (2). Viruses were identified by BLAST search (www.ncbi.nlm.nih.gov/blast) and alignment to GenBank sequences. FSE800 had 96% identity (182 of 188 bp) with the nonstructural (NS) 5 region of the original ILHV strain AY632539 (1). An ILHV original 1944 isolate used as positive control had 100% sequence identity with AY632539.
Limited sequence information is available in GenBank for ILHV outside of the conserved NS5 region. Therefore, further sequencing of the NS5 region using flavivirus consensus primers FU1 and cFD3 (2) and the complete envelope (E) gene region, based on the complete open reading frame ILHV nucleotide sequence AY632539 (1), was conducted on FSE800, as well as a low-passage original 1944 isolate (R. Tesh, University of Texas Medical Branch [UTMB]), 2 mosquito isolates from Iquitos, Peru (R. Tesh, UTMB), and 2 human isolates from Brazil (CDC) (8) (Figure). There was 100% sequence identity among the 2 Brazilian and 2 Peruvian isolates at both gene regions. In the NS5 region, there was 100% identity between Brazilian and original isolates; 95% identity between FSE800 and Brazilian-original isolates; 98% identity between FSE800 and Peruvian isolates; and 96% identity between Peruvian and original-Brazilian isolates. At the protein level, 3 amino acid (aa) differences were found between FSE800 and original-Brazilian isolates, 2 between FSE800-Peruvian and original-Brazilian isolates (aa 3086, Lys-Gln; aa 3138, Ala-Val) and 1 between FSE800 and original-Brazilian-Peruvian isolates (aa 3309, Asp-Asn).
In the E gene region, there was 99.9% identity between original and Brazilian isolates; 95.1% and 95% identity between FSE800 and original and Brazilian isolates, respectively; 98.5% identity between FSE800 and Peruvian isolates; and 95.3% identity between Peruvian and original isolates. At the protein level, 2 aa differences were found between original-Brazilian and Peruvian-FSE800 isolates (aa 432, Ile-Thr; aa 652, Lys-Asn), 1 aa change only in Brazilian isolates (aa 570, His-Tyr), and 1 only in Peruvian isolates (aa 675, Asn-Ser). With the exception of the Ala-Val change, all were nonconservative changes. The effect of the amino acid changes has yet to be determined. However, nucleotide sequence comparison between the 6 ILHV isolates has shown that these gene regions are highly conserved geographically and temporally.
Ilheus virus is not usually associated with human disease, and human ILHV infections may not be correctly identified without a virus isolate because of the similar clinical symptoms and cross-reactivity in serologic assays to other flaviviruses. As laboratory surveillance is enhanced to monitor the emergence of West Nile virus in Central and South America, detection of ILHV and other flaviviruses may increase.
We thank Alfredo Huaman and Roxana Caceda for their expert serologic and isolation assistance, respectively; Robert Tesh for contribution of the 3 ILHV isolates; and Robert S. Lanciotti and Goro Kuno for technical assistance.
- Kuno G, Chang GJ. Biological transmission of arboviruses: reexamination of and new insights into components, mechanisms, and unique traits as well as their evolutionary trends. Clin Microbiol Rev. 2005;18:608–37.
- Kuno G, Chang GJ, Tsuchiya KR, Karabatsos N, Cropp CB. Phylogeny of the genus Flavivirus. J Virol. 1998;72:73–83.
- Monath TP, Heinz F. Flaviviruses. In: Knipe D, Howley P, editors. Fields virology. 4th ed. Philadelphia: Lippincott Williams and Wilkins; 1996. p. 1043–125.
- Laemmert H, Hughes T. The virus of Ilheus encephalitis: isolation, serological specificity and transmission. J Immunol. 1947;55:61–7.
- Srihongse S, Johnson CM. The isolation of Ilheus virus from a man in Panama. Am J Trop Med Hyg. 1967;16:516–8.
- Pinheiro F, Travassos da Rosa A. Ilheus fever. In: Beran G, Steel J, editors. CRC handbook of zoonoses. Boca Raton (FL): CRC Press; 1994. p. 210.
- Figueiredo LT. The Brazilian flaviviruses. Microbes Infect. 2000;2:1643–9.
- Nassar ES, Coimbra TL, Rocco IM, Pereira LE, Ferreira IB, de Souza LT, Human disease caused by an arbovirus closely related to Ilheus virus: report of five cases. Intervirology. 1997;40:247–52.
- Prias-Landinez E, Bernal-Cubides C, Morales-Alarcon A. Isolation of Ilheus virus from a man in Colombia. Am J Trop Med Hyg. 1968;17:112–4.
- Kumar S, Tamura K, Nei M. MEGA3: integrated software for molecular evolutionary genetics analysis and sequence alignment. Brief Bioinform. 2004;5:150–63.
- Figure. Phylogenetic analysis of the NS5 (A) and E gene (B) regions of 6 Ilheus virus (ILHV) isolates. The sequences were aligned in MegAlign (DNASTAR, Inc., Madison, WI, USA); the alignments...
Please use the form below to submit correspondence to the authors or contact them at the following address:
Barbara W. Johnson, Arbovirus Diseases Branch, Division of Vector-Borne Infectious Diseases, Centers for Disease Control and Prevention, 3150 Rampart Rd, Fort Collins, CO 80521, USA;
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: July 05, 2010
- Page last updated: July 05, 2010
- Page last reviewed: July 05, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)